The results of the study show that chronic migraineurs often pursue multiple CAM treatments in spite of low levels of satisfaction with those treatments, while patients who experience relief from traditional treatments are less likely to seek the out additional CAM treatments.
This abstract was published in 2016 showcasing data from Health Union’s PsA, RA, IBD, Plaque Psoriasis & MS In America 2016 surveys.
The results of this study enhance understanding of the use of opioid medication prescribing for chronic migraine sufferers.
Partnering with University of Massachusetts/UMass Memorial Medical Center, this poster was published in 2016 showcasing data from Health Union’s Migraine In America 2014 survey.
The results of the study show that in this online community of RA patients, 72.6% did not have the disease in control and 38.2% had never used a biologic. bDMARD use varied considerably among patient subgroups, particularly by time since RA diagnosis, expected annual out-of-pocket spending, and preferred medication route of administration.
Partnering with University of Massachusetts/UMass Memorial Medical Center, this manuscript was published in November 2015 showcasing data from Health Union’s Migraine In America 2014 survey.
Partnering with Chung-Ang University and University of Colorado, this abstract was published in 2015 showcasing data from Health Union’s Migraine In America 2015 survey.
This poster was published at the World Federation of Mental Health 2015 in Singapore, showcasing data from Health Union’s Migraine In America 2014 survey.
Partnering with University of Colorado – Denver, this poster was published in 2015 showcasing data from Health Union’s Migraine In America 2015 survey.
Partnering with University of Massachusetts/UMass Memorial Medical Center, this abstract was published in 2015 showcasing data from Health Union’s Migraine in America 2012 survey.